Nuvalent Inc vs Teucrium Soybean Fund — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Teucrium Soybean Fund trades at $25.86. Which is the better fit depends on your goals.
| NUVL | SOYB | |
|---|---|---|
Market Cap | $9.81B | — |
Sector | Technology | Commodities - Metals/Agriculture |
52-Week High | $123.96 | $25.88 |
52-Week Low | $72.16 | $21.07 |
Enterprise Value | $8.52B | — |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →